Skip to main content


Fig. 1 | Cardiovascular Diabetology

Fig. 1

From: Heart failure with insulin degludec versus glargine U100 in patients with type 2 diabetes at high risk of cardiovascular disease: DEVOTE 14

Fig. 1

Main and sensitivity analyses of treatment differences in time to first hHF (SMQ definition). *Broad MedDRA search weighted by proportion confirmed in LEADER by the Event Adjudication Committee. There were only 100 events using the broad MedDRA search without the LEADER match, 31 of which were classed as cardiac disorders. CI confidence interval, glargine U100 insulin glargine 100 units/mL, hHF hospitalization for heart failure, HF heart failure, N number of patients, % proportion of patients, SMQ standardized Medical Dictionary for Regulatory Activities Query

Back to article page